Literature DB >> 21855333

Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism.

Yaoyao Jia1, Muhammad Javidul Haque Bhuiyan, Hee-Jin Jun, Ji Hae Lee, Minh Hien Hoang, Hak-Ju Lee, Nahyun Kim, Dongho Lee, Kwang Yeon Hwang, Bang Yeon Hwang, Dal-Woong Choi, Sung-Joon Lee.   

Abstract

In this study, we confirmed that ursolic acid, a plant triterpenoid, activates peroxisome proliferator-activated receptor (PPAR)-α in vitro. Surface plasmon resonance and time-resolved fluorescence resonance energy transfer analyses do not show direct binding of ursolic acid to the ligand-binding domain of PPAR-α; however, ursolic acid enhances the binding of PPAR-α to the peroxisome proliferator response element in PPAR-α-responsive genes, alters the expression of key genes in lipid metabolism, significantly reducing intracellular triglyceride and cholesterol concentrations in hepatocytes. Thus, ursolic acid is a PPAR-α agonist that regulates the expression of lipid metabolism genes, but it is not a direct ligand of PPAR-α.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855333     DOI: 10.1016/j.bmcl.2011.07.095

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  19 in total

1.  Therapeutic potentials of Crataegus azarolus var. eu- azarolus Maire leaves and its isolated compounds.

Authors:  Eman Abu-Gharbieh; Naglaa Gamil Shehab
Journal:  BMC Complement Altern Med       Date:  2017-04-18       Impact factor: 3.659

Review 2.  The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity.

Authors:  Xiaoping Li; Liufeng Zheng; Bing Zhang; Ze-Yuan Deng; Ting Luo
Journal:  Front Nutr       Date:  2022-06-13

3.  SIRT1/Atg5/autophagy are involved in the antiatherosclerosis effects of ursolic acid.

Authors:  Qixiao Jiang; Ranran Hao; Wencheng Wang; Hui Gao; Chunbo Wang
Journal:  Mol Cell Biochem       Date:  2016-08-11       Impact factor: 3.396

4.  Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.

Authors:  Ajit A Kulkarni; Collynn F Woeller; Thomas H Thatcher; Sesquile Ramon; Richard P Phipps; Patricia J Sime
Journal:  PPAR Res       Date:  2012-06-18       Impact factor: 4.964

5.  Characterisation of two oxidosqualene cyclases responsible for triterpenoid biosynthesis in Ilex asprella.

Authors:  Xiasheng Zheng; Xiuxiu Luo; Guobing Ye; Ye Chen; Xiaoyu Ji; Lingling Wen; Yaping Xu; Hui Xu; Ruoting Zhan; Weiwen Chen
Journal:  Int J Mol Sci       Date:  2015-02-05       Impact factor: 5.923

6.  Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.

Authors:  Songtao Li; Xilu Liao; Fanyu Meng; Yemei Wang; Zongxiang Sun; Fuchuan Guo; Xiaoxia Li; Man Meng; Ying Li; Changhao Sun
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

Review 7.  Natural Antioxidant Application on Fat Accumulation: Preclinical Evidence.

Authors:  Proshanta Roy; Daniele Tomassoni; Enea Traini; Ilenia Martinelli; Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Francesco Amenta; Seyed Khosrow Tayebati
Journal:  Antioxidants (Basel)       Date:  2021-05-27

8.  Extract of Kuding tea prevents high-fat diet-induced metabolic disorders in C57BL/6 mice via liver X receptor (LXR) β antagonism.

Authors:  Shengjie Fan; Yu Zhang; Na Hu; Qinhu Sun; Xiaobo Ding; Guowen Li; Bin Zheng; Ming Gu; Feisi Huang; Yin-Qiang Sun; Zhiqin Zhou; Xiong Lu; Cheng Huang; Guang Ji
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

9.  Ursolic acid protects monocytes against metabolic stress-induced priming and dysfunction by preventing the induction of Nox4.

Authors:  Sarah L Ullevig; Hong Seok Kim; Huynh Nga Nguyen; William S Hambright; Andrew J Robles; Sina Tavakoli; Reto Asmis
Journal:  Redox Biol       Date:  2014-01-11       Impact factor: 11.799

Review 10.  Integrated physiology and systems biology of PPARα.

Authors:  Sander Kersten
Journal:  Mol Metab       Date:  2014-03-06       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.